BlackRock, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting results for both the third quarter and the first nine months of the fiscal year.
John C. Lipman, Chief Executive Officer, Director, and 10% owner of Stark Focus Group, Inc., filed an initial statement of beneficial ownership on November 4, 2026, disclosing an indirect interest in 4,150,000 shares of the company's common stock as of a June 16, 2026 …
A Form 144 notice of proposed sale was filed on November 4, 2026, disclosing that Alicia M. Tranen, a director of Ranpak Holdings Corp., intends to sell 5,903 Class A shares through Fidelity Brokerage Services LLC on the NYSE.
Arthur J. Gallagher & Co. officer William F. Ziebell filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 23,510 shares of common stock acquired the same day through a stock option exercise.
Rachel R. Amdahl, SVP and Chief Operations Officer of Eagle Bancorp Montana, Inc., filed a Form 4 on November 4, 2026, disclosing the acquisition of 482 shares of common stock on November 2, 2026.
Director Rick Hays of Eagle Bancorp Montana, Inc. filed a Form 4 on November 4, 2026, disclosing an acquisition of common stock on November 2, 2026, under the company's non-employee director award plan.
Eagle Bancorp Montana, Inc. EVP and CFO Miranda Spaulding filed a Form 4 on November 4, 2026, disclosing the acquisition of 2,429 shares of common stock on November 2, 2026, at no cost under the company's stock incentive plan.
Rare Element Resources Ltd. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing operational and financial information as of that date, with 645,368,390 common shares outstanding as of October 30, 2026.
Rafael Santana, President and CEO of Westinghouse Air Brake Technologies Corporation, filed a Form 4 on November 4, 2026, disclosing the sale of 2,174 shares of common stock across ten transactions on November 2 and 3, 2026, all made pursuant to a Rule 10b5-1(c) …
Salomon Azoulay, an officer of MBX Biosciences, Inc., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 373 shares of common stock on NASDAQ.